Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 17;16(12):1929.
doi: 10.3390/v16121929.

In Vitro Evaluation of the Anti-Chikungunya Virus Activity of an Active Fraction Obtained from Euphorbia grandicornis Latex

Affiliations

In Vitro Evaluation of the Anti-Chikungunya Virus Activity of an Active Fraction Obtained from Euphorbia grandicornis Latex

José Angel Santiago-Cruz et al. Viruses. .

Abstract

Chikungunya virus (CHIKV) is classified as a pathogen with the potential to cause a pandemic. This situation becomes more alarming since no approved drug exists to combat the virus. The present research aims to demonstrate the anti-CHIKV activity of molecules present in the latex of Euphorbia grandicornis. Therefore, a biodirected assay was carried out to find the molecules with anti-CHIKV activity. Extractions with hexane, dichloromethane, and methanol and subsequent purification by column chromatography were carried out to later evaluate cytotoxic activity by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay and antiviral activity by plaque assay. Our findings show that unlike the others, methanolic extract has a low cytotoxic effect and a good anti-CHIKV effect (EC50 = 26.41 µg/mL), which increases when obtaining the purified active fraction (pAFeg1) (EC50 = 0.4835 µg/mL). Time-of-addition suggests that the possible mechanism of action of pAFeg1 could be inhibiting any of the non-structural proteins of CHIKV. In addition, both the cytotoxic and anti-CHIKV activity of pAFeg1 demonstrate selectivity since it killed cancer cells and could not inhibit DENV2.

Keywords: Euphorbia grandicornis; antiviral; cancer cells; chikungunya virus; cytotoxic; latex; oleanolic acid; roburic acid; selectivity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart of the extraction, fractionation, and obtention of an active fraction pAFeg 1 process carried out from Euphorbia grandicornis latex.
Figure 2
Figure 2
Dose–response curve of the cytotoxic activity of the methanol extract. * Represents a p-value < 0.05 with respect to the vehicle control estimated by one-way ANOVA followed by Dunnett’s test.
Figure 3
Figure 3
Evaluation of the cytotoxic activity of fractions obtained from ME. (a) Evaluation of the six fractions obtained; a represents a value of p < 0.05 concerning the control in viability, and b represents p < 0.05 in% PFU/mL. (b) Evaluation of AFeg in different cell lines; 1, 2, and 3 represent a value of p < 0.05 from the indicated concentration concerning the control in A549, HeLa, and HaCat, respectively. p values were estimated by one-way ANOVA followed by Dunnett’s test.
Figure 4
Figure 4
Evaluation of the cytotoxic activity of pAFeg1. * Represents a p-value < 0.05 with respect to the vehicle control estimated by one-way ANOVA followed by Dunnett’s test.
Figure 5
Figure 5
Evaluation of anti-CHIKV activity of ME in VERO cells. * Represents a p-value < 0.05 with respect to the vehicle control estimated by one-way ANOVA followed by Dunnett’s test.
Figure 6
Figure 6
Evaluation of anti-CHIKV activity of pAFeg1 in HaCat cells. * Represents a p-value < 0.05 with respect to the vehicle control estimated by one-way ANOVA followed by Dunnett’s test.
Figure 7
Figure 7
Evaluation of selectivity of pAFeg1. No decrease in the number of PFUs was observed at the concentrations in which CHIKV was inhibited, even at a higher concentration.
Figure 8
Figure 8
Confirmation of the anti-CHIKV activity of pAFeg1 by RT-qPCR. (a) PFU standard curve, (b) inhibition of viral RNA replication. * Represents a p-value < 0.05 with respect to the vehicle control estimated by one-way ANOVA followed by Dunnett’s test.
Figure 8
Figure 8
Confirmation of the anti-CHIKV activity of pAFeg1 by RT-qPCR. (a) PFU standard curve, (b) inhibition of viral RNA replication. * Represents a p-value < 0.05 with respect to the vehicle control estimated by one-way ANOVA followed by Dunnett’s test.
Figure 9
Figure 9
AFeg1 time-of-addition assay.

Similar articles

References

    1. Vairo F., Haider N., Kock R., Ntoumi F., Ippolito G., Zumla A. Chikungunya: Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention. Infect. Dis. Clin. N. Am. 2019;33:1003–1025. doi: 10.1016/j.idc.2019.08.006. - DOI - PubMed
    1. Mason P.J., Haddow A.J. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53; an additional note on Chikungunya virus isolations and serum antibodies. Trans. R. Soc. Trop. Med. Hyg. 1957;51:238–240. doi: 10.1016/0035-9203(57)90022-6. - DOI - PubMed
    1. Weinbren M.P. The occurrence of Chikungunya virus in Uganda. II. In man on the Entebbe peninsula. Trans. R. Soc. Trop. Med. Hyg. 1958;52:258–259. - PubMed
    1. Tsetsarkin K.A., Chen R., Leal G., Forrester N., Higgs S., Huang J., Weaver S.C. Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc. Natl. Acad. Sci. USA. 2011;108:7872–7877. doi: 10.1073/pnas.1018344108. - DOI - PMC - PubMed
    1. Amraoui F., Failloux A.B. Chikungunya: An unexpected emergence in Europe. Curr. Opin. Virol. 2016;21:146–150. doi: 10.1016/j.coviro.2016.09.014. - DOI - PubMed

Publication types

Grants and funding

LinkOut - more resources